Baricitinib could improve the prognosis of anti-MDA5 antibody positive dermatomyositis associated interstitial lung disease.

ABSTRACT:

SUBMITTER: Zhu S 

PROVIDER: S-EPMC12619472 | biostudies-literature | 2025 Nov

REPOSITORIES: biostudies-literature